North East soon get new 20 new ayurvedic healthcare centers

Sripad Naik, Union Minister of State for AYUSH while addressing a national workshop on activities and contribution of the Central Council for Research in Ayurvedic Sciences (CCRAS) said that at least 20 new ayurvedic healthcare centers been set up in Assam, Sikkim and Arunachal Pradesh.

These health care centers will be contributing their health care services to the remote areas of the NE region. Rs. 1.5 crore has been sanctioned for this purpose and the Guwahati center will soon start In-Patient Department services.

While addressing workshop he also said that The CCRAS under the Ministry of AYUSH working and engaged to improve healthcare services, research, and developmental activities in the North-Eastern states since 1971.

Naik also added that our country has got a huge traditional medicinal heritage in the world and enjoys a special status in terms of an indigenous system of healthcare practices.

He also inaugurated the new building of the Regional Ayurveda Research Institute for Gastrointestinal Disorder in Guwahati.

Naik also encouraged state farmers to cultivate more medicinal plants.

 

Related Posts

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

CHENNAI: The Madras High Court on Friday dismissed a petition seeking to quash a First Information Report (FIR) registered against Puducherry-based pharmaceutical entities accused of manufacturing and distributing counterfeit medicines…

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

Chhattisgarh: Riding on policy reforms that earned it the top rank among large states in NITI Aayog’s Investment Friendliness Index 2026 for Regulatory Ease and Institutional Environment, Chhattisgarh has received…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

Pharma companies in a flux over Trump’s 200% tariff move on generics

Pharma companies in a flux over Trump’s 200% tariff move on generics

Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’